OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
MLYS holding history
Mineralys Therapeutics, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLYS overviewAll 13F holders of MLYSFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,110,300
- Value
- $56.9M
- % of portfolio
- 1.1%
- Quarters held
- 9
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,110,300 | $56.9M | 1.1% | +57,400+2.8% | Added | Holders |
| Q1 2026 | 2,052,900 | $55.6M | 1.3% | +1,072,500+109.4% | Added | Holders |
| Q4 2025 | 980,400 | $35.6M | 0.7% | −489,094−33.3% | Reduced | Holders |
| Q3 2025 | 1,469,494 | $55.7M | 1.3% | +709,143+93.3% | Added | Holders |
| Q2 2025 | 760,351 | $10.3M | 0.3% | +760,351 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −1,611,637−100.0% | Sold out | Holders |
| Q4 2024 | 1,611,637 | $19.8M | 0.4% | −391,302−19.5% | Reduced | Holders |
| Q3 2024 | 2,002,939 | $24.3M | 0.4% | −18,485−0.9% | Reduced | Holders |
| Q2 2024 | 2,021,424 | $23.7M | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,021,424 | $26.1M | 0.5% | +2,021,424 | New | Holders |